The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
